These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8247779)

  • 21. Identification of a cellular protein that binds to Tat-responsive element of TGF beta-1 promoter in glial cells.
    Thatikunta P; Sawaya BE; Denisova L; Cole C; Yusibova G; Johnson EM; Khalili K; Amini S
    J Cell Biochem; 1997 Dec; 67(4):466-77. PubMed ID: 9383706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of an amino acid analogue to incorporate p-aminobenzyl-EDTA in peptides.
    Song AI; Rana TM
    Bioconjug Chem; 1997; 8(2):249-52. PubMed ID: 9095368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus.
    Kim SG; Hatta T; Tsukahara S; Nakashima H; Yamamoto N; Shoji Y; Takai K; Takaku H
    Bioorg Med Chem; 1995 Jan; 3(1):49-54. PubMed ID: 8612046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication.
    Brdar B; Matulić M; Rubelj I; Ivanković M; Reich E
    Croat Med J; 2002 Oct; 43(5):591-7. PubMed ID: 12402403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altering the context of an RNA bulge switches the binding specificities of two viral Tat proteins.
    Smith CA; Crotty S; Harada Y; Frankel AD
    Biochemistry; 1998 Jul; 37(30):10808-14. PubMed ID: 9692971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1.
    Lebars I; Richard T; Di Primo C; Toulmé JJ
    Blood Cells Mol Dis; 2007; 38(3):204-9. PubMed ID: 17300966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and anti-influenza virus-A activity of circular dumbbell RNA DNA chimeric oligonucleotides.
    Abe T; Hatta T; Yamakawa H; Takai K; Yokota T; Takaku H
    Nucleic Acids Symp Ser; 1997; (37):219-20. PubMed ID: 9586078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of antisense oligodeoxyribonucleotides and their anti-HIV activity.
    Gug-Kim S; Suzuki Y; Nakashima H; Yamamoto N; Takaku H
    Nucleic Acids Symp Ser; 1991; (25):103-4. PubMed ID: 1842040
    [No Abstract]   [Full Text] [Related]  

  • 29. Antisense oligonucleotide derivatives as gene-targeted drugs.
    Knorre DG; Vlassov VV
    Biomed Sci; 1990 Apr; 1(4):334-43. PubMed ID: 1723003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical cross-linking of the human immunodeficiency virus type 1 Tat protein to synthetic models of the RNA recognition sequence TAR containing site-specific trisubstituted pyrophosphate analogues.
    Naryshkin NA; Farrow MA; Ivanovskaya MG; Oretskaya TS; Shabarova ZA; Gait MJ
    Biochemistry; 1997 Mar; 36(12):3496-505. PubMed ID: 9131999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candidate HIV-1 Tat vaccine development: from basic science to clinical trials.
    Ensoli B; Fiorelli V; Ensoli F; Cafaro A; Titti F; Buttò S; Monini P; Magnani M; Caputo A; Garaci E
    AIDS; 2006 Nov; 20(18):2245-61. PubMed ID: 17117011
    [No Abstract]   [Full Text] [Related]  

  • 32. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    EMBO J; 1998 Dec; 17(23):7056-65. PubMed ID: 9843510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complementary large loops determine the rate of RNA duplex formation in vitro in the case of an effective antisense RNA directed against the human immunodeficiency virus type 1.
    Homann M; Rittner K; Sczakiel G
    J Mol Biol; 1993 Sep; 233(1):7-15. PubMed ID: 8377194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insertional gene synthesis, a novel method of assembling consecutive DNA sequences within specific sites in plasmids. Construction of the HIV-1 tat gene.
    Ciccarelli RB; Loomis LA; McCoon PE; Holzschu DL
    Nucleic Acids Res; 1990 Mar; 18(5):1243-8. PubMed ID: 2157195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antisense oligodeoxynucleotide: inhibitor of splicing of mRNA of human immunodeficiency virus.
    Daum T; Engels JW; Mag M; Muth J; Lücking S; Schröder HC; Matthes E; Müller WE
    Intervirology; 1992; 33(2):65-75. PubMed ID: 1568836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poly(L-lysine)-conjugated oligonucleotides promote sequence-specific inhibition of acute HIV-1 infection.
    Degols G; Leonetti JP; Benkirane M; Devaux C; Lebleu B
    Antisense Res Dev; 1992; 2(4):293-301. PubMed ID: 1284042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic oligonucleotides for biomedical applications.
    Seliger H; Fröhlich A; Gröger G; Krist B; Montenarh M; Rösch H; Rösch R; Ortigao FR
    Nucleic Acids Symp Ser; 1991; (24):193-6. PubMed ID: 1726743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide.
    Bongartz JP; Aubertin AM; Milhaud PG; Lebleu B
    Nucleic Acids Res; 1994 Nov; 22(22):4681-8. PubMed ID: 7984418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisense DNA-analogs. Inhibition of human immunodeficiency virus.
    Ebright Y; Raska K; Gaur S; Frenkel L; Tsao J; Stein S
    N J Med; 1990 Dec; 87(12):1011-5. PubMed ID: 2270148
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro transport and delivery of antisense oligonucleotides.
    Hughes J; Astriab A; Yoo H; Alahari S; Liang E; Sergueev D; Shaw BR; Juliano RL
    Methods Enzymol; 2000; 313():342-58. PubMed ID: 10595365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.